Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study, Stratified, Non-randomized, Estimating SBRT Efficiency and Toxicity in Primary and Secondary Liver Tumors

NCT03408665 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT03408665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03408665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study, Stratified, Non-randomized, Estimating SBRT Efficiency and Toxicity in Primary and Secondary Liver Tumors
Lead sponsor
Centre Oscar Lambret
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 13, 2019
Completion date
January 31, 2027
Enrollment
280 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer, liver metastases